Der Ziege Polyklonal anti-DOCK1 Antikörper wird verwendet zum Nachweis von DOCK1 in Proben von Human, Maus, Ratte, Rind (Kuh), Hund und Schwein. Er wurde validiert für WB.
Western blot: 3-4 μg/mL. Approx 150-200 kDa band seen in A431 cell lysate. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
0.5 mg/mL
Buffer
Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C.
Target
DOCK1
(Dedicator of Cytokinesis 1 (DOCK1))
Andere Bezeichnung
DOCK1 / DOCK180
Hintergrund
The DOCK1 protein is involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. It also functions as a guanine nucleotide exchange factor (GEF), which activates Rac Rho small GTPases by exchanging bound GDP for free GTP. The GEF activity of the DOCK1 protein may be enhanced by ELMO1.Synonyms: 180 kDa protein downstream of CRK, Dedicator of cytokinesis protein 1